Orencia 125 mg/1 ml, Injektionslösung zur subkutanen Anwendung (Fertigpen)

7680658330013 CH-65833 Injektionslösung
Orencia 125 mg/1 ml, Injektionslösung zur subkutanen Anwendung (Fertigpen)
Orencia 125 mg/1 ml, Injektionslösung zur subkutanen Anwendung (Fertigpen)
Orencia 125 mg/1 ml, Injektionslösung zur subkutanen Anwendung (Fertigpen)
1 / 3
google

Article details

Package size
4
Selling units
4
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/10/2024
Patient information leaflet
Français
24/10/2024
Patient information leaflet
Italien
24/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
125.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.32 MG Substance HBESI

Reimbursement information

Public price
CHF 1044.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2018

Authorization holder

Bristol-Myers Squibb SA

6312 Steinhausen

Authorization information

Swissmedic authorization number
65833
Drug name
Orencia, Injektionslösung zur subkutanen Anwendung (Fertigpen)
Galenic form
SUPA
ATC Code
L04AA24
Authorization status
Z
Dispensing category
B
First authorization
15/03/2016
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis

Package details

Description (FR)
ORENCIA sol inj 125 mg/ml stylo pré-remp 4 x 1 ml
Description (DE)
ORENCIA Inj Lös 125 mg/ml Fertpen 4 x 1 ml
Market launch
15/03/2016
Narcotic (BTM)
No